A case of severe osteomalacia secondary to phosphate diabetes in a renal transplant recipient

International Urology and Nephrology

Volumn 45, Issue 6, 2013, Pages 1795-1799

  Sayegh, Johnny ^a,b   Augusto, Jean François ^a,b   Chappard, Daniel ^a,b   Insalaco, Paolo ^a,b   Subra, Jean François ^a,b  

^a LUNAM Universite   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Hypophosphatemia; Kidney transplantation; Osteomalacia; Phosphate diabetes; Sirolimus; Tacrolimus

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; ALKALINE PHOSPHATASE BONE ISOENZYME; ANALGESIC AGENT; MEDRONATE TECHNETIUM TC 99M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERALIZATION; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; END STAGE RENAL DISEASE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LOW DRUG DOSE; MALE; MIDDLE AGED; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

BONE DENSITY CONSERVATION AGENTS; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPOPHOSPHATEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOMALACIA; PHOSPHORUS; SIROLIMUS; TACROLIMUS;

EID: 84890798224     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0283-0     Document Type: Article

References (13)

1. Ghanekar H, Welch BJ, Moe OW, Sakhaee K (2006) Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens 15(2):97-104
2. K/DOQI (2003) Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1-S201
3. Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2(7929):309-310
4. Heaf JG (2003) Bone disease after renal transplantation. Transplantation 75(3):315-325
5. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH (2000) High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11(6):1093-1099
6. Bouvard B, Audran M, Legrand E, Chappard D (2009) Ultrastructural characteristics of glucocorticoid-induced osteoporosis. Osteoporos Int 20(6):1089-1092
7. Laroche M, Boyer JF (2005) Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine 72(5):376-381
8. Evenepoel P, Meijers BK, de Jonge H, Naesens M, Bammens B, Claes K et al (2008) Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 3(6):1829-1836
9. Al-Ibrahim A, Sanjed S, Al-Abbad A, Al-Sabban E, Al-Shaibani K (2004) Post renal transplantation tubulopathies in children: a 9-year experience at a tertiary care centre. Saudi J Kidney Dis Transpl 15(1):27-33
10. Bayrakci US, Baskin E, Ozcay F, Ozdemir BH, Karakayali H, Haberal M (2008) Renal Fanconi syndrome and myopathy after liver transplantation: drug-related mitochondrial cytopathy? Pediatr Transplant 12(1):109-112
11. Simon N, Morin C, Urien S, Tillement JP, Bruguerolle B (2003) Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria. Br J Pharmacol 138(2):369-376
12. Falkiewicz K, Kaminska D, Nahaczewska W, Boratynska M, Owczarek H, Klinger M et al (2006) Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation. Transplant Proc 38(1):119-122
13. Schwarz C, Bohmig GA, Steininger R, Mayer G, Oberbauer R (2001) Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression. Nephrol Dial Transplant 16(2):378-382